Trial Profile

A Phase 3, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of AGN-190584 in Participants With Presbyopia

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 15 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Jan 2024 Results of pooled analysis from GEMINI 1 and 2, evaluating the efficacy of topical pilocarpine HCl, published in the Journal of Cataract and Refractive Surgery
28 Apr 2022 According to an AbbVie media release, data will be presented at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting.
19 Apr 2022 According to an AbbVie media release, pooled results from GEMINI 1 and GEMINI 2 studies will be presented at the 2022 American Society for Cataract and Refractive Surgery (ASCRS) Annual Meeting being held April 22 -26 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com